AIRNA Raises USD 155 Million in Oversubscribed Series B Financing to Advance RNA Editing Therapies April 1, 2025
FTI Co-Leads USD 45.8 million Investment in RegCell to Accelerate Development of Treg therapy for Autoimmune Diseases March 22, 2025
FTI Announces Additional Investment in Neusignal Therapeutics to Develop Alzheimer’s Treatment February 17, 2025
SONIRE Therapeutics Receives FDA Breakthrough Device Designation for HIFU Pancreatic Cancer Treatment October 10, 2024
Medii Raises Series A Funding to Enhance “E-Consult,” An Exclusive Online Consultation Service for Physicians March 15, 2024
Fast Track Initiative (FTI) invests in Shinobi Therapeutics, a U.S. and Japan-based company developing hypoimmune iPS cell therapy December 12, 2023
Global Vascular Secures Series A Funding to Advance Innovative Nanotechnology for Peripheral Artery Disease Treatment December 5, 2023
Two of FTI’s portfolios receive significant nondilutive funding from AMED to support their pipeline development December 1, 2023
Fast Track Initiative Invests in CellFiber, Pioneering Cell Mass Production Technology November 9, 2023
